ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Neurolief receives CE mark for Relivion biospectrumasia
July 10, 2019The Relivion is the first non-invasive, adaptive multi-channel brain neuromodulation technology that offers a highly effective therapy, without the risks and costs associated with invasive procedures and without the side effects related to medications.
Pharma Sources Insight January 2025
